Supplementary Figures – Androgen receptor expression and its prognostic value in T1N0 Luminal/HER2− breast cancer
figure
posted on 2022-03-01, 09:35 authored by Figshare Future Science GroupFigshare Future Science Group, Xi Wang, Wenjing Zhong, Jiarong Yi, Haoming Wu, Xuxiazi Zou, Jikun Feng, Xinjian Huang, Siqi Li
Supplementary Figure 1. Androgen receptor expression and its prognostic value in T1N0 Luminal/HER2− breast cancer Survival curves stratified by adjuvant ET regimen. Recurrence-free and distant recurrence-free survival according to androgen receptor (AR) expression in patients receiving OFS+TAM/AI (A,B), TAM (C,D) and AI (E,F)
Supplementary Figure 2. Androgen receptor expression and its prognostic value in T1N0 Luminal/HER2− breast cancer Survival curves stratified by adjuvant CT regimen. Recurrence-free and distant recurrence-free survival according to androgen receptor (AR) expression in patients receiving AC (A,B), TC (C,D) and TAC (E,F) |